Want to see RDHL full AI Analyst Report?
RedHill Biopharma (RDHL) Stock Forecast & Price Target
RDHL Analyst Ratings
There are no analyst ratings in the last 3 months.
RDHL Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | $0.37→$0.43 | hold | -3.62%Downside | Upgraded | 11/03/26 | ||
| Google Drug Manufacturers - Specialty and Generic | TipRanks - Google | $0.36→$0.42 | sell | -6.11%Downside | Reiterated | 11/03/26 | ||
| Anthropic Drug Manufacturers - Specialty and Generic | TipRanks - Anthropic | $0.37→$0.42 | hold | -4.75%Downside | Upgraded | 11/03/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | $0.37→$0.42 | hold | -4.75%Downside | Reiterated | 11/03/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | $0.37→$0.42 | sell | -5.20%Downside | Reiterated | 11/03/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | $0.37→$0.42 | sell | -5.20%Downside | Downgraded | 11/03/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 11/03/26 | $0.37→$0.43 | hold | -3.62%Downside | Upgraded | TipRanks - PerPlexity | ||
| Google Drug Manufacturers - Specialty and Generic | 11/03/26 | $0.36→$0.42 | sell | -6.11%Downside | Reiterated | TipRanks - Google | ||
| Anthropic Drug Manufacturers - Specialty and Generic | 11/03/26 | $0.37→$0.42 | hold | -4.75%Downside | Upgraded | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 11/03/26 | $0.37→$0.42 | hold | -4.75%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 11/03/26 | $0.37→$0.42 | sell | -5.20%Downside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 11/03/26 | $0.37→$0.42 | sell | -5.20%Downside | Downgraded | TipRanks - xAI |
Best Analysts Covering RedHill Biopharma
Copying DeepSeek Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +14.27% per trade.
Copying DeepSeek Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +14.27% per trade.
Copying DeepSeek Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +14.27% per trade.
RDHL Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, RDHL has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RDHL average Analyst price target in the past 3 months is ―.
RDHL Financial Forecast
RDHL Earnings Forecast
Next quarter’s earnings estimate for RDHL is -$1.01 with a range of ― to ―. The previous quarter’s EPS was -$1.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
RDHL Sales Forecast
Next quarter’s sales forecast for RDHL is $0 with a range of ― to ―. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
